TARSUS PHARMACEUTICALS

Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors

12 Aug 2021 06:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Reports Second Quarter 2021 Financial Results and Provides Business and Clinical Updates

04 Aug 2021 14:30:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021

24 Jul 2021 15:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference

07 Jul 2021 13:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. to Participate in the Raymond James 2021 Human Health Innovation Conference

22 Jun 2021 03:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Announces Positive Results of Saturn-1 Pivotal Trial Evaluating TP-03 for the Treatment of Demodex Blepharitis

21 Jun 2021 03:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Schedules Conference Call and Webcast to Announce Saturn-1 Phase 2b/3 Pivotal Trial Results for TP-03 for the Treatment of Demodex Blepharitis

18 Jun 2021 13:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease

16 Jun 2021 13:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual Healthcare Conference

24 May 2021 13:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business and Clinical Updates

11 May 2021 13:05:01 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Initiates Saturn-2, Second Pivotal Phase 3 Trial Evaluating the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

06 May 2021 13:05:01 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of Investigational New Drug Application for TP-05 for Lyme Disease Prevention

04 May 2021 13:05:01 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Presents Results of Pioneering Atlas Study at ARVO 2021 Annual Meeting Demonstrating the Functional and Psychosocial Impact of Demodex Blepharitis

03 May 2021 13:08:25 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference

27 Apr 2021 13:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Reports Full-Year 2020 Financial Results and Business and Clinical Updates

31 Mar 2021 13:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals and LianBio Announce Strategic Partnership to Develop and Commercialize TP-03 in Greater China for the Treatment of Demodex Blepharitis and Meibomian Gland Disease

29 Mar 2021 13:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Appoints Bryan Wahl, MD, JD as General Counsel

19 Jan 2021 05:30:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Appoints Dianne Whitfield as Chief Human Resources Officer

07 Jan 2021 06:24:29 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. to Present at the 2021 ICR Virtual Conference

05 Jan 2021 14:00:00 By Nasdaq GlobeNewswire